Fondaparinux is used to prevent a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs. It is marketed by GlaxoSmithKline. Reference standards of Fondaparinux API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Fondaparinux Sodium for Assay (COLD SHIPMENT REQUIRED) (1282707)
Catalogue No.:PA USP1282707
CAS :
Molecular Formula : NA
Molecular Weight : NA
Fondaparinux Sodium Identification (1282718)
Catalogue No.:PA USP1282718
Fondaparinux Sodium System Suitability Mixture A (1282729)
Catalogue No.:PA USP1282729
Fondaparinux Sodium System Suitability Mixture B (1282730)
Catalogue No.:PA USP1282730
Fondaparinux
Catalogue No.:PA 33 36000
Molecular Formula : C31H53N3O49S8
Molecular Weight : 1508.22
(3S,4S,5S,6R)-6-(((3R,4S,5R,6R)-6-(((3S,4R,5R,6R)-2-Carboxy-4-hydroxy-6-(((3S,4S,5S)-4-hydroxy-5-(hydroxymethyl)-2-((sulfooxy)methyl)tetrahydrofuran-3-yl)oxy)-5-(sulfooxy)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfoamino)-4-(sulfooxy)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3S,4S,5S)-4,5-dihydroxy-3-(sulfoamino)-6-((sulfooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylic Acid
Catalogue No.:PA 33 36510
Molecular Formula : C30H50N2O46S7
Molecular Weight : 1399.12
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
